Scaffold Hopping in Tuberculosis Drug Discovery: Principles, Applications, and Case Studies
Journal of Medicinal Chemistry · 23.10.2025 · 68 (20) · 20903-20929
DOI: 10.1021/acs.jmedchem.5c01100 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 07.10.2025. Verfasst von Ondrej Kovar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, Hradec Kralove 500 03, Czech Republic. Hauptthemen laut MEDLINE: Antitubercular Agents, Drug Discovery, Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grantov? Agentura Cesk? Republiky, European Cooperation in Science and Technology, Ministerstvo Obrany Cesk? Republiky.
Abstract (Originalsprache)
Tuberculosis (TB) imposes a major global health challenge, aggravated by the emergence of drug-resistant Mycobacterium tuberculosis (Mtb) strains. Scaffold hopping, a medicinal chemistry approach that modifies the molecular backbone of known bioactive compounds, has emerged as a promising tool in the development of novel drugs, including TB therapeutics. This perspective provides an insight into the application of scaffold hopping across varying degrees of structural modifications, highlighting successful case studies targeting key Mtb pathways, including energy metabolism, cell wall synthesis, proteasome function, and respiratory processes. Beyond traditional and in silico methods, scaffold hopping has spurred the discovery of compounds with improved pharmacological profiles, such as improved pharmacokinetics, enhanced efficacy, reduced toxicity, and resistance circumvention. The findings support scaffold hopping’s potential to address the limitations of current anti-TB drugs as a versatile and innovative approach to accelerate TB drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, Hradec Kralove 500 03, Czech Republic.
- Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove 500 03, Czech Republic.
- Department of Toxicology and Military Pharmacy, Military Faculty of Medicine, University of Defence, Trebesska 1575, Hradec Kralove 500 01, Czech Republic.
- U.S. Army CCDC Chemical Biological Center, Aberdeen Proving Ground, Maryland, Maryland 21010-5424, United States.
ORCID-Profile: Vladimir Finger, Ondrej Soukup, Jaroslav Roh, Jan Korabecny
Förderung
- Grantov? Agentura Cesk? Republiky
- European Cooperation in Science and Technology
- Ministerstvo Obrany Cesk? Republiky
- Grantov? Agentura, Univerzita Karlova
- National Institute of virology and bacteriology
Zitieren
APA
Kovar, O., Kufa, M., Finger, V., Soukup, O., Kratky, M., Torruellas, C., Roh, J., & Korabecny, J. (2025). Scaffold Hopping in Tuberculosis Drug Discovery: Principles, Applications, and Case Studies. Journal of Medicinal Chemistry, 68(20), 20903-20929. https://doi.org/10.1021/acs.jmedchem.5c01100
Vancouver
Kovar O, Kufa M, Finger V, Soukup O, Kratky M, Torruellas C, et al. Scaffold Hopping in Tuberculosis Drug Discovery: Principles, Applications, and Case Studies. Journal of Medicinal Chemistry. 2025;68(20):20903-20929. doi:10.1021/acs.jmedchem.5c01100
BibTeX
@article{Kovar2025,
author = {Kovar, Ondrej and Kufa, Martin and Finger, Vladimir and Soukup, Ondrej and Kratky, Martin and Torruellas, Carilyn and Roh, Jaroslav and Korabecny, Jan},
title = {Scaffold Hopping in Tuberculosis Drug Discovery: Principles, Applications, and Case Studies},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {20},
pages = {20903--20929},
doi = {10.1021/acs.jmedchem.5c01100}
}
EUVIMED